Salute e Benessere

BioSenic publishes new evidence of beneficial effects of arsenic trioxide…

INSIDE INFORMATIONSBioSenic publishes new evidence of beneficial effects of arsenic trioxide treatment supporting clinical trial for systemic sclerosisArsenic trioxide (ATO) therapeutic potential to treat systemic sclerosis (SSc) is now confirmed in a new preclinical model - Fra2- characterized by severe pulmonary lesionsMont-Saint-Guibert, Belgium, September 19, 2023, 7.00 am CEST – BIOSENIC(Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in...
Nasdaq GlobeNewswire
19/09/2023

ONWARD® Reports 2023 Half Year Results and Business Update

/2014)US commercialization of ARC-EX™ expected 2H 2024 with USD 30,000 anticipated price Clinical study initiated pairing ARC Therapy™ with a brain-computer interface to restore use of legsandupper extremities ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announced its first 2023 half results and provided a Business Update...
Nasdaq GlobeNewswire
19/09/2023

ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility

To diversify its operational scope, the new facility will be designed to accommodate different scales of production. Initially, it will introduce three new production lines, with capacities of 1.8 mol (large scale), 400 mmol (mid scale), and 100 mmol (small scale), and the facility has flexibility to add two more lines for future growth. To diversify its operational scope, the new facility will be designed to accommodate different scales of production. Initially, it will introduce three new...
PR Newswire
19/09/2023

Ceva Santé Animale launches the 2024 edition of its "Call for Projects" to help…

Through the "Call for Projects" program, the company seeks to harness the expertise and creativity of individuals, startups, and organizations to address key issues in animal health and develop groundbreaking solutions that will benefit companion animals worldwide. Through the "Call for Projects" program,the company seeks to harness the expertise and creativity of individuals, startups, and organizations to address key issues in animal health and develop groundbreaking…
PR Newswire
19/09/2023

Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by…

Key Takeaways from the Head and Neck Squamous Cell Carcinoma Market Report Key Takeaways from the Head and Neck Squamous Cell Carcinoma Market Report Discover which therapies are expected to grab the major head and neck squamous cell carcinoma market share @Head and Neck Squamous Cell Carcinoma Market Report Head and Neck Squamous Cell Carcinoma Overview Head and neck squamous cell carcinoma (HNSCC) is a type of cancer that originates in the squamous cells lining the mucous...
PR Newswire
18/09/2023

COMPASS Pathways appoints Daphne Karydas to its Board of Directors

“Daphne is an ideal match for the COMPASS Pathways Board of Directors as we progress our phase 3 COMP360 psilocybin program in treatment-resistant depression and our phase 2 programs in anorexia nervosa and post-traumatic stress disorder,” said George Goldsmith, Chairman of the COMPASS Pathways Board of Directors. “Her deep industry experience, her interdisciplinary approach to implementing growth strategies for biopharma, and her understanding of investor priorities will help ensure that...
Nasdaq GlobeNewswire
18/09/2023

Groupe Casino: Update on the negotiations with the holders of notes issued by…

Update on the negotiations with the holders of notes issued by QuatrimRequest to extend the conciliation proceedings Paris, 18 September 2023As announced on 27 July 2023, Casino Group has continued negotiations with the ad hoc group of holders of the notes issued by Quatrim representing a majority of noteholders (the “ Ad Hoc Group ”) in view of agreeing on the treatment of the Quatrim notes as part of the agreement in principle entered into on 27 July 2023 by Casino with EP Global Commerce a...
Nasdaq GlobeNewswire
18/09/2023

Vistin Pharma ASA: Mandatory notification of trade

Saga Pure ASA has on 18 September 2023 purchased 100,000 shares in Vistin Pharma ASA at NOK 23,50 per share. After the transaction Saga Pure ASA has a holding of 100,000 shares, corresponding to 0.23 % ownership. Saga Pure ASA is closely associated with board member Øystein Stray Spetalen. Attachment 20230918_Notification of trade_Saga i Vistin
Nasdaq GlobeNewswire
18/09/2023

Kyrgyzstan, Ukraine, and Uzbekistan Update National Guidelines for…

The decision for rapid roll-out of the six-month all oral regimens for cases of DR-TB was significantly driven by the BPaL regimen's performance in operational research conducted in countries participating in the LIFT-TB (Leveraging Innovation for Faster Treatment of Tuberculosis) project, in addition to a December 2022 update of the World Health Organization's (WHO) guidelines for treating DR-TB that recommended using the BPaL and BPaLM regimens. The decision for rapid roll-out of the...
PR Newswire
18/09/2023

Sobi publishes the preliminary outcome of the rights issue

As a result of the rights issue, Sobi will receive proceeds amounting to approximately SEK 6,024 million before issue costs. Through the rights issue, Sobi's share capital will increase by SEK 23,275,903.56, from SEK 170,832,200.70 to SEK 194,108,104.26 and the total number of shares in Sobi will increase by 42,419,668. After the rights issue, the number of shares in Sobi will amount to 353,756,464, all of which are common shares.[1] As a result of the rights issue, Sobi will receive proceeds...
PR Newswire
18/09/2023

AB Science provides an update on the EMA timetable for examination of the…

PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON THE EUROPEAN MEDICINES AGENCY'S TIMETABLE FOR EXAMINATIONOF THE MARKETING AUTHORIZATION APPLICATION OF MASITINIBINAMYOTROPHIC LATERAL SCLEROSISBASED ON THE UPDATED TIMETABLE, A DECISION FROM THE EUROPEAN MEDICINES AGENCY IS EXPECTED DURING THE FIRST QUARTER OF 2024Paris, 18 September , 2023 ,6pm CETAB Science SA(Euronext – FR0010557264 – AB) today provided an update on the...
Nasdaq GlobeNewswire
18/09/2023

Abu Dhabi Stem Cells Center Successfully Manufactures UAE's First CAR-T Cell to…

The procedure involved manufacturing the cellular product (CAR-T), which relies on the use of immune cells from the patient, at ADSCC's Good Manufacturing Practices (GMP) laboratories – one of very few laboratories in the Middle East. The treatment took five weeks, during which Murad was admitted at ADSCC, the only accredited Centre of Excellence in Hematopoietic Stem Cell Transplantation in Abu Dhabi. Physicians withdrew the cells from the patient and genetically modified his immune cells in…
PR Newswire
18/09/2023

International Supermodel and Bestselling Author Maye Musk Shares Life-Changing…

A Champion Against Sexism & Ageism An advocate for various social issues, sexism and ageism are two that are close to Musk's heart. In a recent survey by Niix, it was revealed that "39% of women think they're made to feel passed their sell-by date after 40, and 35 percent of women feel as though they should have "made-it" career wise by this age". Musk, however, believes you must redefine aging for yourself. A Champion Against Sexism & Ageism An advocate for various…
PR Newswire
18/09/2023

Global investors wielding US$500 billion in capital eye new opportunities in…

The inaugural SuperBridge Summit, taking place from 16-17 October 2023 at Dubai's iconic Museum of the Future is a unique platform converging more than 500 investors, business, government, policy and cultural leaders from 20 countries to accelerate investment and co-creation opportunities in hitherto untapped and under-explored markets. The inaugural SuperBridge Summit, taking place from16-17 October 2023atDubai'siconic Museum of the Future is a unique platform converging more than 500...
PR Newswire
18/09/2023

Biosimilar Monoclonal Antibody Market to Reach $64.6 Billion, Globally, by 2032…

Request Sample of the Report on Biosimilar Monoclonal Antibody Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/3671 Biosimilar antibodies are used for many research applications. Monoclonal antibodies are highly effective in treating a wide range of diseases, including cancer, autoimmune disorders, and inflammatory conditions. Prime determinants of growth Increase in prevalence of chronic diseases globally, rise in number of product approvals...
PR Newswire
18/09/2023

Glueless Wigs Market to Reach $1.3 billion, Globally, by 2032 at 6.3% CAGR…

Request Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/145034 Request Sample Copy of the Report:https://www.alliedmarketresearch.com/request-sample/145034 The popularity of glueless wigs among people of all ages & genders is increasing rapidly. Glueless wigs come pre-attached with combs, bands, and straps for attachment to your head. This type of wig is very easy to fix and remove. Prime determinants of growth The rising level of hair fall...
PR Newswire
18/09/2023

Poultry Health Market Size is Expected to Reach USD 6.00 billion by 2025, with a…

This business intelligence assesses the market based on various parameters. The growth drivers, restraints, opportunities, and challenges are well elaborated in this report. It contains accurate revenue projections, estimated CAGR, past valuation, and present growth rate of this industry vertical. Apart from that, the major segments and regions are evaluated accurately with an aim to determine the size and scope of the overall market. The key players are highlighted with prime emphasis on their…
PR Newswire
18/09/2023

Flavors And Fragrances Market size worth USD 48,296.01 Million, Globally, by…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=28106 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=28106 Browse in-depth TOCon" Flavors And Fragrances Market " 202 - Pages 126 – Tables 37 – Figures Market Research Report Highlights Key Drivers, Outlook, and Key Players in the Flavors and Fragrances Industry The global Flavors and Fragrances Market continues to evolve, driven by various...
PR Newswire
18/09/2023

Myasthenia Gravis Treatment Market to Grow Exponentially by 2029 | Brandessence…

This business intelligence report provides a deep-down assessment of the key trends and dynamics of this market space. The growth drivers, restrains, challenges, and opportunities are well explained in this study. By procuring this report, businesses can get make informed strategic decisions. Apart from that, it also includes credible statistical data such as past valuable, grow rate, along with revenue projections of this business sphere. The market segments, geographical landscape, and…
PR Newswire
18/09/2023

Wearable Devices and IoT Revolutionize Healthcare Monitoring and Weight…

Utilizing a remote patient monitoring system for ongoing well-being tracking can significantly contribute to averting the advancement of weight gain and mitigating potentially life-threatening medical issues, all while assisting the patient in their weight loss journey. Therefore, such devices can be helpful for patients combating obesity and those who struggle with weight loss. Obesity stands as a significant medical concern, elevating the likelihood of various other illnesses and health…
PR Newswire
18/09/2023

Latest Blood Cancer Treatment Updates Presented at Annual NCCN Event During…

The live event is taking place September 22-23, 2023, at the Hilton San Francisco Union Square. For full details and to register, visit NCCN.org/hem. The live event is taking place September 22-23, 2023, at the Hilton San Francisco Union Square. For full details and to register, visitNCCN.org/hem. "We designed a comprehensive program for the entire hematology and oncology team—taking into account the latest advances, conversations, and controversies in blood cancer treatment today,"...
PR Newswire
18/09/2023

Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution…

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical research across North American and European markets HOLLISTON, Mass. and LYON, France, Sept.18, 2023(GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) and Etisense announced today that they have entered into an agreement to offer DECRO®, Etisense's non-invasive telemetry jacket and...
Nasdaq GlobeNewswire
18/09/2023

Evaxion expands preclinical bacterial vaccine pipeline in collaboration with…

AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine is currently available Evaxion's proprietary AI-platforms EDEN™ and RAVEN™ will be utilized for rapid design of a completely novel vaccine candidate capable of eliciting both a humoral (antibody) and cellular immune response to the pathogenCollaborative and co-funded project between two companies with strong scientific alignment and complementary skill sets and capabilitiesThis collaboration...
Nasdaq GlobeNewswire
18/09/2023

Scar Treatment Market to Grow Exponentially by 2029 | Brandessence Market…

This business intelligence report offers a scrutiny of the top factors reshaping the trends and dynamics of this market space. It has been curated with an aim to help businesses make informed decisions by providing them with credible data related to numerous aspects of this market. Alongside, the major segments and regions are evaluated accurately with an aim to determine the size and scope of the overall market. The report also contains accurate revenue projections, estimated CAGR, past…
PR Newswire
18/09/2023
Altri  Comunicati